Zdrowie i gospodarka · 10/12/2021

FDA Classifies Ingested, Transient, Space Occupying Device for Weight Management and/or Weight Loss into Class II

The US Food and Drug Administration (FDA) is classifying the ingested, transient, space occupying device for weight management and/or weight loss into Class II, requiring special controls to ensure its safety and effectiveness. This move aims to improve patients' access to innovative weight loss devices.